Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
Do you recommend plasmapheresis prior to kidney transplantation for patients with elevated panel-reactive antibody percentages?
Related Questions
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
What are the best practices for preparing blood for transfusion in a patient with a kidney transplant to minimize complications?
Are there instances when you use letermovir without the addition of acyclovir when managing a kidney transplant recipient for CMV prophylaxis?
Do you recommend non-bypass bariatric surgeries over intestinal bypass procedures for kidney transplant-eligible candidates to prevent oxalate nephropathy, given the higher risk of kidney oxalate deposition with intestinal bypass?
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
Should HCQ be continued in an asymptomatic SLE patient who has received renal transplant?
Would you rely on virtual crossmatch alone to proceed with a kidney transplant?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
